arginine has been researched along with vorinostat in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Classen, CF; Fiedler, T; Hering, S; Kreikemeyer, B; Linnebacher, M; Maletzki, C; Redanz, U; Rosche, Y; Strauss, M; William, D | 1 |
| Booth, S; Cheng, P; Craddock, C; De Santo, C; Fultang, L; Kearns, P; Keeshan, K; Mussai, F; Perry, T; Sarrou, E; Stavrou, V; Wheat, R | 1 |
1 review(s) available for arginine and vorinostat
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine and vorinostat
| Article | Year |
|---|---|
Targeting the arginine metabolic brake enhances immunotherapy for leukaemia.
Topics: Acute Disease; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Arginase; Arginine; Azacitidine; Humans; Immunotherapy; K562 Cells; Leukemia, Myeloid; Receptors, Chimeric Antigen; Sialic Acid Binding Ig-like Lectin 3; T-Lymphocytes; Tumor Microenvironment; Vorinostat | 2019 |
2 other study(ies) available for arginine and vorinostat
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Lyase; Argininosuccinate Synthase; Benzopyrans; Cell Line, Tumor; Cell Proliferation; Chloroquine; DNA Methylation; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hydrolases; Hydroxamic Acids; Male; Mice, Inbred Strains; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pyogenes; Treatment Outcome; Tumor Burden; Vorinostat; Xenograft Model Antitumor Assays | 2015 |